During this webinar, Stefan Jellbauer of Thermo Fisher Scientific will discuss recent advances in evaluation of vaccine quality control and safety, as well as cytokine/chemokine profiling utilizing the QuantiGene multiplex gene expression assays and Procarta Plex multiplex protein detection assays. There will also be a discussion on the available service offerings from Thermo Fisher Scientific for these assay platforms followed by Q&A. For the second presentation, Chetana Revankar of Thermo Fisher Scientifc will present an overview of Thermo Fishers’ drug discovery capabilities and enabling technologies to accelerate the drug discovery and development process followed by Q & A.
Presenters:
3pm - Dr Stefan Jellbauer, Product Manager Quantigene expression Assays, Protein and Cell Analysis, Luminex-based immunoassays for multiplex RNA and protein detection to support drug discovery and vaccine development
4pm - Dr Chetana Revankar, Senior Staff Scientist Cell Biology, Drug Discovery & Development services – Building better models for disease research
Attendance: Free and open to all
This webinar is part of a two-part series. To continue the discussion, please register for the session on 13 May here.
You can follow @OneNucleus on Twitter.
